Publications (155,367)

Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

Schneeweiss A, Ettl J, Lüftner D, Beckmann M, Belleville E, Fasching P, Fehm TN, et al. (2020)

Journal article

Zirzlmeier J, Schrettl S, Brauer JC, Contal E, Vannay L, Brémond É, Jahnke E, et al. (2020)

Journal article

Balima LH, Gebrekirstos A, Kouamé FN, Nacoulma BMI, Thiombiano A, Bräuning A (2020)

Journal article

Sampath Kumar H, Herrmann L, Tsogoeva S (2020)

Journal article, Review article

Schäfer W, Schmidt T, Cordsmeier A, Borges V, Beare PA, Pechstein J, Schulze-Luehrmann J, et al. (2020)

Journal article

Stemick J, Gauer LC, Wihan J, Moceri S, Xiang W, von Hörsten S, Kohl Z, Winkler J (2020)

Journal article

Würfel F, Hübner H, Häberle L, Gaß P, Hein A, Jud S, Hack C, et al. (2020)

Journal article

Kopyto M, Lechler S, von der Gracht HA, Hartmann E (2020)

Journal article

Förner A, Giese S, Arnold C, Felfer P, Körner C, Neumeier S, Göken M (2020)

Journal article

Antonakakis M, Schrader S, Aydin Ü, Khan A, Gross J, Zervakis M, Rampp S, Wolters CH (2020)

Journal article

‹ 1 ... 4,382 4,383 4,384 4,385 4,386 ... 15,537 ›